OBI Pharma, Inc. (TPEX:4174)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
62.00
+1.90 (3.16%)
Apr 2, 2025, 1:30 PM CST

OBI Pharma Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
1,732899.284,7412,5123,338
Upgrade
Short-Term Investments
1,3991,88330.71140-
Upgrade
Trading Asset Securities
0.090.230.751.77383.53
Upgrade
Cash & Short-Term Investments
3,1312,7824,7732,6543,722
Upgrade
Cash Growth
12.53%-41.70%79.83%-28.69%-23.44%
Upgrade
Accounts Receivable
4.26.482.043.471.45
Upgrade
Other Receivables
19.0123.5926.2419.817.57
Upgrade
Receivables
23.2130.0728.2723.2719.02
Upgrade
Inventory
27.7325.9321.979.567.36
Upgrade
Prepaid Expenses
258.01221.43211.26167.35146.6
Upgrade
Other Current Assets
-100.34---
Upgrade
Total Current Assets
3,4403,1605,0342,8543,895
Upgrade
Property, Plant & Equipment
1,1651,2491,1761,149918.22
Upgrade
Long-Term Investments
959.851,0708.739.118.04
Upgrade
Goodwill
--61.1561.1561.15
Upgrade
Other Intangible Assets
62.8473.18321.29337.14392.73
Upgrade
Other Long-Term Assets
26.1351.6432.976.2164.9
Upgrade
Total Assets
5,6545,6046,6344,4875,340
Upgrade
Accounts Payable
301.270.771.140.530.16
Upgrade
Accrued Expenses
-58.54112.49177.8267.69
Upgrade
Short-Term Debt
0.414.3115.71-9.47
Upgrade
Current Portion of Long-Term Debt
34.097779
Upgrade
Current Portion of Leases
55.1249.8640.3552.0737.08
Upgrade
Current Income Taxes Payable
10.391.580.560.341.11
Upgrade
Current Unearned Revenue
7.786.293.16--
Upgrade
Other Current Liabilities
3.330.2840.7389.47123.98
Upgrade
Total Current Liabilities
412.37158.62221.14327.22248.49
Upgrade
Long-Term Debt
48.2260.0667.072835
Upgrade
Long-Term Leases
366.79425.89163.03205.96155.41
Upgrade
Long-Term Deferred Tax Liabilities
--46.3354.7663.2
Upgrade
Other Long-Term Liabilities
6.015.890--
Upgrade
Total Liabilities
833.39650.45497.57615.95502.09
Upgrade
Common Stock
2,6322,2942,2941,9931,993
Upgrade
Additional Paid-In Capital
9,1017,1286,9333,7023,685
Upgrade
Retained Earnings
-7,879-5,569-4,523-2,909-1,378
Upgrade
Treasury Stock
-26.53-26.53-45.99-45.99-53.83
Upgrade
Comprehensive Income & Other
-12.09-19.87-26.32-24.53-16.79
Upgrade
Total Common Equity
3,8153,8074,6322,7164,229
Upgrade
Minority Interest
1,0061,1471,5041,155608.74
Upgrade
Shareholders' Equity
4,8204,9536,1363,8714,838
Upgrade
Total Liabilities & Equity
5,6545,6046,6344,4875,340
Upgrade
Total Debt
504.63547.11293.15293.03245.95
Upgrade
Net Cash (Debt)
2,6262,2354,4792,3613,476
Upgrade
Net Cash Growth
17.49%-50.10%89.73%-32.08%-24.19%
Upgrade
Net Cash Per Share
11.249.7620.1711.8717.50
Upgrade
Filing Date Shares Outstanding
246.37229.25229.11198.95198.89
Upgrade
Total Common Shares Outstanding
246.37229.25229.11198.95198.89
Upgrade
Working Capital
3,0273,0014,8132,5273,646
Upgrade
Book Value Per Share
15.4816.6120.2213.6521.26
Upgrade
Tangible Book Value
3,7523,7344,2502,3183,775
Upgrade
Tangible Book Value Per Share
15.2316.2918.5511.6518.98
Upgrade
Land
--87.5187.5187.51
Upgrade
Buildings
-343.2370.02329.28328.66
Upgrade
Machinery
-1,0221,054671.26695.35
Upgrade
Construction In Progress
-66.4635.74368.45117.37
Upgrade
Leasehold Improvements
-181.24184.0665.8573.74
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.